 | | PRD_000205 | | Name: | DESVANCOSAMINYL VANCOMYCIN | | Formula: | C59 H62 Cl2 N8 O22 | | Description: | DESVANCOSAMINYL VANCOMYCIN IS AN INTERMIDIATE IN VANCOMYCIN BIOSYNTHESIS. IT IS TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED
BY D-GLUCOSE (RESIDUE 8) ON RESIDUE 4. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000971 | | Name: | N-acetylglycyl-N-[(3S)-1-hydroxy-5-methyl-2-oxohexan-3-yl]-L-serinamide | | Formula: | C14 H25 N3 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000206 | | Name: | VANCOMYCIN AGLYCON | | Formula: | C53 H52 Cl2 N8 O17 | | Description: | VANCOMYCIN AGLYCON IS THE NONSUGAR COMPONENT OF VANCOMYCIN, CONSISTING OF THE TRICYCLIC HEPTAPEPTIDE ONLY. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000972 | | Name: | N-(benzylsulfonyl)-D-valyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide | | Formula: | C25 H33 Cl N4 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000207 | | Name: | Decaplanin | | Formula: | C72 H86 Cl N9 O28 | | Description: | DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L,
GLYCOSYLATED | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000209 | | Name: | Teicoplanin A2-2 beta-D-Glucopyranuronic acid | | Formula: | C88 H97 Cl2 N9 O33 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000976 | | Name: | N-acetyl-L-valyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-isoleucinamide | | Formula: | C22 H36 N4 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000210 | | Name: | Teicoplanin Aglycone | | Formula: | C58 H45 Cl2 N7 O18 | | Description: | TEICOPLANIN AGLYCON IS THE NONSUGAR COMPONENT OF
TEICOPLANIN, CONSISTING OF THE TETRACYCLIC
HEPTAPEPTIDE ONLY. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000977 | | Name: | 1-acetyl-L-prolyl-L-threonyl-N-[(2R,3S)-4-chloro-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-L-serinamide | | Formula: | C24 H35 Cl N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000211 | | Name: | A40926 | | Formula: | C88 H95 Cl2 N9 O34 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000212 | | Name: | Microcystin LR | | Formula: | C49 H75 N10 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000980 | | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-methyl-L-leucinamide | | Formula: | C16 H26 N3 O5 P | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000981 | | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-alanine | | Formula: | C18 H28 N3 O7 P | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000213 | | Name: | motuporin | | Formula: | C40 H57 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000982 | | Name: | (2S)-2-({N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl}amino)butanoic acid | | Formula: | C19 H30 N3 O7 P | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000214 | | Name: | NODULARIN-R | | Formula: | C41 H61 N8 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000983 | | Name: | N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-norvaline | | Formula: | C20 H32 N3 O7 P | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000215 | | Name: | DIHYDROMICROCYSTIN-LA | | Formula: | C46 H69 N7 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000984 | | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-isoleucine | | Formula: | C21 H34 N3 O7 P | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000216 | | Name: | LEUPEPTIN | | Formula: | C20 H41 N6 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000985 | | Name: | N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-ethyl-L-leucinamide | | Formula: | C17 H28 N3 O5 P | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000217 | | Name: | Daptomycin | | Formula: | C72 H101 N17 O26 | | Description: |
DAPTOMYCIN IS AN ACIDIC CYCLIC LIPOPEPTIDE.
THE SCAFFOLD IS MADE OF TWO PARTS:
(1) THREE RESIDUES N-TERM EXOCYCLIC PART
(2) A DECAPEPTIDE LACTONE RING DERIVED FROM
CYCLISATION OF THR3 SIDE CHAIN ONTO THE C-TER
CARBOXYL GROUP
THE N-DECANOYL FATTY ACID IS LINKED TO THE
MAIN BODY OF THE MOLECULE VIA N-TERM ACYLATION. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000986 | | Name: | N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucylglycine | | Formula: | C17 H26 N3 O7 P | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000219 | | Name: | GRAMICIDIN S | | Formula: | C60 H92 N12 O10 | | Description: | GRAMICIDIN S IS A DECAPEPTIDE,
RESIDUES 1 AND 10 FORM A PEPTIDE BOND
RESULTING IN CYCLIZATION. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000987 | | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-valine | | Formula: | C20 H32 N3 O7 P | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
